{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:01:08Z","timestamp":1792555268665,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.msard.2020.102017","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T04:18:34Z","timestamp":1582517914000},"page":"102017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-7076","authenticated-orcid":false,"given":"A","family":"Fuerte-Hortig\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"L\u00f3pez Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JDG","family":"Hiraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"S\u00e1nchez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dotor Garc\u00eda-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"P\u00e1ramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Ruiz-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Navarro-Mascarell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Eichau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msard.2020.102017_bib0001","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40265-019-01135-8","article-title":"A review in relapsing\u2013remitting multiple sclerosis","volume":"79","author":"Teriflunomide","year":"2019","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.msard.2020.102017_bib0002","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/1352458517741191","article-title":"Fulminant rebound of relapsing\u2013remitting multiple sclerosis after discontinuation of dimethyl fumarate: a case report","volume":"24","author":"Harmel","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102017_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.07.014","article-title":"Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis","volume":"380","author":"Yamout","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102017_bib0004","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/17512433.2017.1395280","article-title":"Tolerability and efficacy of colestipol hydrochloride for accelerated elimination of teriflunomide","volume":"10","author":"Robertson","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.msard.2020.102017_bib0005","unstructured":"Sanofi. Aubagio EMA summary of product characteristics, 2013."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:47:15Z","timestamp":1761900435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820300936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":5,"alternative-id":["S2211034820300936"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102017","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102017"}}